JP2024525766A5 - - Google Patents

Info

Publication number
JP2024525766A5
JP2024525766A5 JP2024501929A JP2024501929A JP2024525766A5 JP 2024525766 A5 JP2024525766 A5 JP 2024525766A5 JP 2024501929 A JP2024501929 A JP 2024501929A JP 2024501929 A JP2024501929 A JP 2024501929A JP 2024525766 A5 JP2024525766 A5 JP 2024525766A5
Authority
JP
Japan
Prior art keywords
subject
disease
alzheimer
dione
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024501929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525766A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073747 external-priority patent/WO2023288284A1/en
Publication of JP2024525766A publication Critical patent/JP2024525766A/ja
Publication of JP2024525766A5 publication Critical patent/JP2024525766A5/ja
Pending legal-status Critical Current

Links

JP2024501929A 2021-07-14 2022-07-14 アミロイドベータオリゴマー化の阻害剤及びその治療用途 Pending JP2024525766A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163203245P 2021-07-14 2021-07-14
US63/203,245 2021-07-14
PCT/US2022/073747 WO2023288284A1 (en) 2021-07-14 2022-07-14 Inhibitors of amyloid beta oligomerization and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
JP2024525766A JP2024525766A (ja) 2024-07-12
JP2024525766A5 true JP2024525766A5 (https=) 2025-07-23

Family

ID=84919716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501929A Pending JP2024525766A (ja) 2021-07-14 2022-07-14 アミロイドベータオリゴマー化の阻害剤及びその治療用途

Country Status (6)

Country Link
US (1) US20240325319A1 (https=)
EP (1) EP4370496A4 (https=)
JP (1) JP2024525766A (https=)
CN (1) CN117881650A (https=)
AU (1) AU2022311958A1 (https=)
WO (1) WO2023288284A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025019870A1 (en) * 2023-07-20 2025-01-23 Northwestern University Use of neuronal nitric oxide synthase inhibitors in alzheimer's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065205A1 (en) * 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US20090143433A1 (en) * 2004-12-01 2009-06-04 Curt Hendrix Cocktail for modulation of alzheimer's disease
WO2009036275A1 (en) * 2007-09-13 2009-03-19 Link Medicine Corporation Treatment of neurodegenerative diseases using indatraline analogs
ES2668556T3 (es) * 2008-11-20 2018-05-18 Northwestern University Derivados de pirazolona útiles en el tratamiento de esclerosis lateral amiotrófica
WO2011059821A2 (en) * 2009-10-29 2011-05-19 Cambria Pharmaceuticals, Inc. Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

Similar Documents

Publication Publication Date Title
JP2019031502A5 (https=)
JP2019059760A5 (https=)
JP2024109585A5 (https=)
JP2009526751A5 (https=)
JP2022191257A5 (https=)
JP2025092508A5 (https=)
JP2018506555A5 (https=)
JP2004529143A5 (https=)
JP2002522485A5 (https=)
JP2023175694A5 (https=)
JP2020534270A5 (https=)
JP2025510572A5 (https=)
JP2016523260A5 (https=)
BRPI0414347A (pt) associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade
JP2024525766A5 (https=)
JP2024528127A5 (https=)
JPWO2023195530A5 (https=)
JP2024512425A5 (https=)
JP2025502266A5 (https=)
JP2009062388A5 (https=)
JP2005502579A5 (https=)
JP2021530543A5 (https=)
JP2023156372A5 (https=)
CN115697386A (zh) 一种治疗帕金森病的方法和药物
TWI351950B (en) Use of (halobenzyloxy) benzylamino-propanamides fo